Inhibrx Biosciences, Inc.

Inhibrx Biosciences is a clinical-stage biotechnology company focused on developing novel therapeutic candidates to help patients with life-threatening conditions. They leverage their proprietary single-domain antibody (sdAb) platform and expertise in protein engineering to create innovative treatments that address complex target biology. Their mission is to discover and develop effective biologic therapeutics for people with life-threatening conditions, particularly those with unmet medical needs where other approaches have failed or are suboptimal.

Inhibrx's unique sdAb platform is designed to be versatile, highly developable, precisely engineered, multivalent, and multispecific, enabling the creation of therapeutics with superior attributes and mechanisms of action. Their pipeline includes two differentiated clinical-stage candidates, INBRX-109 (a tetravalent DR5 agonist) and INBRX-106 (a hexavalent OX40 agonist), which are being investigated for their potential in treating various types of cancer. Inhibrx is committed to innovation, collaboration, and building a team that is as dynamic and driven as their technology.

Inhibrx Biosciences offers flexible work arrangements to its employees, including flexible schedules and the option to work from home. This allows for a more balanced work-life integration and caters to the needs and preferences of their diverse workforce.

Inhibrx offers a comprehensive benefits package to its employees, including 100% employer-paid insurance, market-competitive salaries, paid holidays, tuition reimbursement, 100% employer-paid family leave, a 401(k) with company match, equity grants, flexible schedules, and the option to work from home.

Inhibrx Biosciences, Inc. is a clinical-stage biotechnology company dedicated to developing novel and effective biologic therapies for people with life-threatening conditions. Anchored by their proprietary single-domain antibody platform and protein engineering expertise, they aim to address complex target biology and deliver superior therapeutic candidates with optimized mechanisms of action. Their mission is driven by a commitment to scientific innovation and excellence, and they foster a collaborative and growth-oriented environment to attract and retain the brightest minds in the industry.

Inhibrx fosters a collaborative and innovative culture that prioritizes employee well-being and encourages scientific risk-taking. Their headquarters in San Diego offers flexibility and autonomy, emphasizing cross-disciplinary collaboration over departmental silos. They promote a close-knit, creative, and adventurous team environment, with a shared vision and intrinsic motivation to push the boundaries of what's possible. This collaborative spirit is complemented by a strong commitment to inclusion, ensuring a diverse workforce reflective of their commitment to serving patients.

Inhibrx is committed to fostering a diverse and inclusive workplace that values the unique perspectives and backgrounds of its employees. They believe that a diverse workforce leads to better innovation and ultimately better serves their patients. They are dedicated to fair hiring practices and maintaining a workforce that reflects the diversity of their scientific research. This commitment to inclusion is evident in their efforts to create a growth-oriented and supportive work environment, offering benefits like unlimited vacation, flexible schedules, and work-from-home options.